• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERZ NORTH AMERICA, INC RADIESSE DERMAL FILLER; INJECTABLE IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERZ NORTH AMERICA, INC RADIESSE DERMAL FILLER; INJECTABLE IMPLANT Back to Search Results
Catalog Number UNKNOWN
Device Problem Malposition of Device (2616)
Patient Problems Erythema (1840); Occlusion (1984); Swelling (2091)
Event Date 08/17/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).The patient's injection site has recovered.There is some minor redness that could be reduced with laser treatments.The device history record for the injected radiesse lot was not reviewed as the lot number was unknown.Device not returned to the manufacturer.
 
Event Description
A female patient was injected with 0.85cc of radiesse to the nose (nasal tip-0.1ml, columella-0.3ml, root-0.45 ml) on (b)(6) 2015.The patient experienced severe swelling after the injection compared with previous treatment.On (b)(6) 2015, the patient was started on antibiotics three times daily prophylactically by the injector.On (b)(6) 2015, the patient was given gentamycin and cephamycin intravenously and orally, along with warm compresses to the area.On (b)(6) 2015, the patient went to the (b)(6) for wound treatment.The "chief of hospital diagnosis" suspected patient had cellulitis and patient was hospitalized.On (b)(6) 2015, the patient began having hyperbaric oxygen therapy (hbot) twice daily.The patient had a total of 16 hbot through (b)(6) 2015, when she was discharged.(b)(6) 2015, the patient's nose tip still has redness & the patient keeps doing hbot.On (b)(6) 2015, the patient did not go back to the hospital for a final examination but visited another physician with her photographs.The physician considered that the diagnosis should be vascular occlusion, not cellulitis.The patient's injection site has recovered.There is some minor redness that could be reduced with laser treatments.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIESSE DERMAL FILLER
Type of Device
INJECTABLE IMPLANT
Manufacturer (Section D)
MERZ NORTH AMERICA, INC
6501 six forks rd
raleigh NC 27615
Manufacturer (Section G)
MERZ NORTH AMERICA, INC
4133 courtney rd
franksville WI 53126
Manufacturer Contact
ann metz
6501 six forks rd
raleigh, NC 27615
9195828000
MDR Report Key5097304
MDR Text Key26550478
Report Number2135225-2015-00062
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P050052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Report Date 08/25/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-